Clinical Trial Update: Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ITCA 650 as add-on to metformin against empagliflozin and glimepiride; study terminated with results and safety/tolerability data pend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Glimepiride (glimepiride)
• ITCA 650
• metformin (metformin)

Snippet

Sponsor: Intarcia Therapeutics | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED